Moreover, the expression of genes associated with cell proliferation, such as CDK1, CDK4, CCNA2, and PLK1, was significantly diminished in the lung-resident fibroblasts of IPF patients treated with nintedanib as compared to vehicle (Figure 7D). Here, CDK1 is linked to idiopathic pulmonary fibrosis.